Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
Corresponding author: Diana Ionescu, Email: email@example.com
Published: Journal of Medical and Radiation Oncology 1 (2021) 157-160, , , - DOI: 10.53011/JMRO.2021.01.16
Professor’s Diana Ionescu Perspective
Dr. Ionescu is a graduate of University of Medicine and Pharmacy “Iuliu Hatieganu” in Cluj Napoca, Romania (1995). She completed her postgraduate training in Anatomical and Clinical Pathology at the University of Pittsburgh Medical Center (2005) and a Fellowship in Gynecological Pathology at Vancouver General Hospital (2006). Dr. Ionescu is board certified in Anatomical Pathology in USA (American Board of Pathology, 2006) and Canada (Royal College of Physicians and Surgeons, 2006). She has practiced as a Consultant Pathologist at BC Cancer Agency in Vancouver since 2006 and is the Medical Director for Clinical Trials at BCC Laboratory. She is currently a Clinical Professor of Pathology at UBC (since 2014), and served as the residency program director for the Anatomic Pathology Residency Program between 2009 and 2017.
Her specific areas of diagnostic expertise are lung, gynecologic and breast pathology. She is an author of over 70 scientific publications and book chapters. She is the author and invited speaker at numerous regional, national and international lectures. Her investigation interests include oncologic pathology and molecular biomarkers, lung cancer and adult health education. She is the Canadian Anatomic and Molecular Pathology (CAMP, since 2016) and CAMP pathology Oncology Digital Series (CAMP-PODS, since 2020) founder and course director.
Dr. Ionescu is an enthusiastic advocate of pathologists participating in numerous patient education forums, TV shows, advocacy and fundraising campaigns, being Spokesperson for College of American Pathologists, Medical Advisor for Lung Cancer Canada, moderator, presenter and community excellence awardee at ROMPOST TV on Omni TV, and in 2015 supporting biomarker testing before the House of Commons Committee on Health.